Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

TECHSTEP LANSERER MYTOS I SVERIGE

Techstep ASA lanserer nå tjenestene til Mytos i det svenske markedet. Målet er å forsterke sin posisjon innen Mobile as a Service (MaaS), og tilby nordiske kunder en enklere og mer mobil arbeidsdag. Mytos har befestet sitt grep i det norske Telecom Expense Management (TEM) markedet med over 150.000 brukere i offentlig og privat sektor. Nå lanserer morselskapet Techstep ASA løsningen i det svenske markedet, og forsterker med dette sin tjenesteportefølje i nabolandet. Nordisk etterspørselSatsingen kommer som et resultat av stor etterspørsel i det svenske markedet og fra nordiske

Phase II-trial DIAGNODE-2 ahead of World Diabetes Day now open to include patients

Diamyd Medical's pivotal trial DIAGNODE-2 is now open for booking patients. The diabetes vaccine Diamyd® for intralymphatic administration will be delivered to the clinics participating in the trial that can begin screening patients. DIAGNODE-2 comprises about 80 patients from Spain, the Czech Republic and Sweden between the ages of 12-24 who have been diagnosed with type 1 diabetes in the last 6 months.“Given the highly promising data we have seen from DIAGNODE-1, it is of course a great event and a potential opportunity for diabetes patients, and we are particularly pleased that we can

Oncology-focused Ascelia Pharma strengthens its board of directors to support international expansion

Malmö-based Ascelia Pharma, a specialty pharmaceutical company dedicated to the development of novel medicines to improve the life expectancy and quality of life for people living with cancer, is strengthening its current board of directors with the addition of Helena Wennerström and Hans Maier as the company prepares to continue its growth journey.”With our two strong drug candidates – Mangoral® and Oncoral – we are ready to take Ascelia Pharma to the next level. We are very pleased that Helena Wennerström and Hans Maier will be joining the board and sharing their valuable expertise and

Detsky Mir, MedLife, Canvest Environmental Protection Group and Globant recognised at the 14th annual East Capital Awards

East Capital, a specialist asset manager in emerging and frontier markets, today announces the winners of the 2017 East Capital Awards: ·  Detsky Mir               Best Growth Award ·  MedLife                    Best IPO Award ·  Canvest                    Discovery of the Year Award ·  Globant                    Best Corporate Governance This is the 14th year that the East Capital Awards honour remarkable companies in East Capital’s investment universe. Peter Elam Håkansson, Chairman and CIO of East Capital, said: “The Awards serve to highlight some of the most outstanding

KappAhl estimates lower sales during the first quarter

KappAhl AB (publ.) estimates that their operating profit for the first quarter 2017/2018 will be lower than the first quarter 2016/2017.        – Sales during the quarter has not lived up to our expectations so far. This is mainly depending on our price- and campaign strategy that has not given the effect we wished for in the tough market climate during the fall, says KappAhl’s President and CEO Danny Feltmann.KappAhl estimates that the operating profit for the first quarter 2017/2018 will be approximately 100 MSEK, compared to 145 MSEK for the first quarter 2016/2017. Sales during the

New study backs up earlier findings – omega-6 fatty acids do not promote low-grade inflammation

The higher the serum linoleic acid level, the lower the CRP, according to a new study from the University of Eastern Finland. Linoleic acid is the most common polyunsaturated omega-6 fatty acid. The findings were published in the European Journal of Clinical Nutrition. It has been speculated that a high intake of omega-6 polyunsaturated fatty acids may increase the risk of several chronic diseases by promoting low-grade inflammation, among other things. The reasoning behind this speculation is that in the human body, linoleic acid is converted into arachidonic acid (also an omega-6 fatty

Kungsleden rents out 5 800 sq.m at Gärdet Frihamnen

Kungsleden has signed a lease agreement of 5 400 square meter with HD Resources in the Rotterdam 1 property and a lease agreement of 400 square meter with InfoZone in the Tegeludden 13 property. The properties are located in Kungsleden's cluster Stockholm City Öst, in the expansive area at Gärdet / Frihamnen.Kungsleden owns four office buildings with a total of 89 000 square meter in the Stockholm City Öst cluster at Gärdet / Frihamnen. The area, Norra Djurgårdsstaden, is part of Stockholm's largest urban development area. Gärdet / Frihamnen has a very attractive location close to both

Multiconsult ASA – Repurchase of own shares

On 10 November 2017, Multiconsult ASA ("Multiconsult") purchased 4 000 of its own shares at an average price of NOK 81.48 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 127 528 of its own shares.  For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

AMERICANS ARE PRO-CONNECTIVITY, EVEN IN ONE OF THE FEW PLACES LEFT TO POWER DOWN

Allianz Global Assistance Discovers That Americans Want Free In-Flight Texting, Wi-Fi and Cellular Calls, but Don’t Want their Fellow Passengers to Use itThose who thought that airplanes might remain a haven from emails, text messages and phone calls may want to think again. The majority of Americans would use free Wi-Fi (76.2 percent) and cellular calls (55.5 percent), and nearly half (44.7 percent) would use free text messaging services if provided on a flight, according to a new survey* conducted by leading travel insurance provider Allianz Global Assistance 

Philanthropists Frank & Margarita Leon Host 4th Annual “Evening of Hope” on Sunday, November 19, 2017 at LaLoggia Restaurant

-- 100% of proceeds will provide critically needed spinal surgeries for some of the world's most disadvantaged children at the FOCOS Orthopedic Hospital in Ghana --WHO: Restaurateur Frank Leon and his attorney wife Margarita Manduley are hosting their Fourth Annual Evening of Hope charity benefit to help pediatric patients in critical need of life-altering spinal surgeries at the FOCOS (The Foundation of Orthopedics and Complex Spine) Orthopedic Hospital in Ghana. The world’s leading pediatric orthopedic surgeon and FOCOS founder, Dr. Oheneba Boachie , will

Invitation to Capital Market Day 2017 with TargetEveryones

TargetEveryone hereby invites analytics, investors and media to our Capital Market Day in Oslo at November 22, 2017. The purpose with the Capital Market Day is to present an updated strategy and financial goals of TargetEveryone. Key speaker will be the CEO of TargetEveryone, Bjorn Forslund, and other prominent guests from the business. Place: Hoyres Hus, Stortingsgaten 20, Oslo Day and time: Wednesday November 22 at 08.00 a.m. CET Please register no later than Tuesday, 21 November 2017. For a complete program and registering please contact Jan Benjaminson; jan@targeteveryone.

DNB ASA - Share buy-back:Transactions during week 45

During week 45 2017, DNB ASA has purchased 910,000 own shares at an average price of NOK 159.06 per share. During this programme DNB ASA has bought 2,995,034 own shares and now owns a total of 8,370,068 own shares. The repurchase of shares is part of the new share buy-back programme announced by DNB ASA on 21 September 2017. The buy-back programme comprises up to approximately 8.1 million shares, of which up to approximately 5.4 million will be repurchased in the open market. The rest will be redeemed from the state of Norway on a proportionate basis, subject to approval from DNB ASA’s

Successful digital mining project continues

By using the latest mobile network technology, Swedish companies, universities and research institutes have collaborated to make it possible to remote control and automate activities in the mine. The project will now continue with the objective to enable mining operators, maintenance personnel, equipment and machines from different suppliers to be connected and share data. That will create increased safety and productivity in the mine. An innovative way of thinking that enables new services that also can be used in other industries. The participating partners in PIMM DMA, the Digitalized

Announcement of managers' transactions: Grevermond Investments Ltd has purchased shares in Caverion Corporation on November 8, 2017

Caverion Corporation Stock exchange release November 10, 2017 at 5.00 p.m. EETAnnouncement of managers' transactions: Grevermond Investments Ltd has purchased shares in Caverion Corporation on November 8, 2017 Person subject to the notification requirement Name: Grevermond Investments Ltd Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Rosenlew Michael Position: Member of the Board Issuer: Caverion Oyj LEI: 7437007ECQWVPCJIS695 Notification type: INITIAL NOTIFICATION Reference number:

Goldenberg Dermatology first in the US to offer SciBase’s Nevisense screening for early detection of melanoma

November 9th SciBase announced that the Company had received the first order in the US from Goldenberg Dermatology, a premier New York City dermatology practice of Dr. Gary Goldenberg and Dr. Kristina Goldenberg. The order, consisting of a Nevisense system and single-use electrodes, means that Drs. Goldenberg will be the first dermatologists in the US to be able to offer the Nevisense test for early detection of melanoma and atypical moles (nevi). Earlier this fall, at the Fall Clinical Dermatology Conference SciBase was mentioned as one of the ten most important new technologies within skin

Karessa Pharma AB presents at Stora Aktiedagen the 13th of  November 2017

Michael Brobjer, CEO at Karessa Pharma AB will present the company's latest development and updates at Stora aktiedagen at Sheraton in Stockholm on Monday the 13thof November. The presentation will be live streamed and can be followed at http://www.aktiespararna.se/tv/live. About Karessa's pharmaceutical projects for treatment of erectile dysfunctionCurrent treatment of impotence is well proven and has a favorable safety profile, but many patients are bothered by the delayed onset and that it may vary depending on food intake. These problems are a consequence of the drug being given as

Veidekke ASA: Invitation to presentation on the Swedish residential market

Veidekke invites you to attend a presentation of our report on the Swedish residential market on Monday 20 November at 11 a.m. at Veidekke Sweden's headquarters at Svetsarvägen 15, Solna, Stockholm. The Swedish residential market is a report series published by Veidekke Sweden. The autumn edition includes an updated forecast of the economic climate for residential construction based on macro-economic assumptions in addition to statistics on housing starts. The report also analyses developments in the autumn of 2017. In a final chapter, proposals of further credit restrictions and

Letter of Intent regarding affiliate assets within the Nordics

Net Gaming has signed an exclusive Letter of Intent regarding the acquisition of several affiliate assets. These will operate primarily within Sweden, but also in the UK, driving traffic throughout paid media channels.The operation of these affiliate assets is growing fast. Currently, they are expected to generate quarterly revenues of approximately EUR 400,000, with an operating margin in the region of 50 percent. The acquisition of these assets is expected to be finalised after completion of due diligence procedures. The initial purchase price amounts to EUR 3,000,000, of which EUR 2,

Stena Line customers donate 61 807 cups of Mercy

Today the donations from Stena Line’s coffee campaign were handed over to Tomas Fransson, National Director at Mercy Ships Sweden. In total Stena Line customers made 61 807 donations during the campaign, which is equivalent to keeping an operating room running for two weeks onboard the hospital ship Africa Mercy. Tomas Fransson, National Director Mercy Ships Sweden and Niclas Mårtensson, CEO Stena Line. “We are very happy that so many of Stena Line customers chose to support our work. It has also been great to see the enthusiasm and engagement among the employees at Stena Line

Apetit Plc - Managers' Transactions

Apetit Plc, Managers' Transactions,  on November 10th, 2017 at 3:30 p.m EET   -------Person subject to the notification requirement                             Name:                                 Merive OyPosition:                              Closely associated personLegal person:                      Yes   -------Person discharging managerial responsibilities in issuerName:                                 Veijo MeriläinenPosition:                              Member of the Board   ------- Initial notificationReference:

Episurf Medical’s CEO Pål Ryfors acquires shares corresponding to 3.2% of capital and 6.8% of votes from main shareholder Serendipity Ixora

Episurf Medical’s (NASDAQ: EPIS B) CEO Pål Ryfors and the company’s largest shareholder Serendipity Ixora have today reached an agreement in which Pål Ryfors acquires 983,607 A-shares in Episurf Medical, corresponding to 3.2% of the capital and 6.8% of the votes from Serendipity Ixora. Following this transaction, Pål Ryfors will be the company’s second largest shareholder counting by the votes. Following the transaction, Serendipity Ixora will hold 4,661,519 A-shares corresponding to 15.3% of capital and 32.3% of the votes in the company. Pål Ryfors will own 983,607 A-shares and 32,786 B-

CORRECTION: Asetek Provides Progress Update on Undisclosed Data Center Customer

Correction to the below notice published at 13:00 hrs CET today - please note that it was dated incorrectly. The correct date for the stock exchange release is November 10, 2017. Below is the corrected notice: November 10, 2017 – Asetek (ASETEK.OL): Reference is made to stock exchange release issued on 22 February 2017, in which Asetek announced the signing of a product development agreement with an anonymous major player in the data center space. The customer has informed Asetek it now targets product launch in March 2018, instead of as originally planned at the SC17 trade show

#17-1064 Listing of Turbo warrants issued by Commerzbank AG

As from November 13, 2017, 13 Turbo warrants issued by Commerzbank AG will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: Commerzbank AG Type of security: Put Turbo warrants of European type Execution: Automatic cash settlement Term: As from November 13, 2017 to expiry date Market Maker: Commerzbank AG Underlying: DAX 30 Index OMXS30 index For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390

There are no items matching the current filter
There are no more items matching the current filter
Back to top